The anti-mouse CD25 antibody (clone PC61) can block IL-2 signaling28 just as two anti-human CD25 antibodies in the clinic, basiliximab and daclizumab, which were used for multiple sclerosis or acute organ rejection through blocking IL-2 signaling29,30. Here, IL2 is linked to multiple sclerosis.